- $34.22m
- -$17.65m
- $1.68m
Brief: Akili Reports Job cuts And Announces Business Transformation To Non-Prescription Model
Akili Inc reports results for the quarter ended in June - Earnings Summary
Brief: Akili, Inc. Q2 adjusted net income USD -12.6 million
Akili Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Centerra Gold, gold miners, Travere Therapeutics
U.S. STOCKS ON THE MOVE-VerifyMe, Intel, Hewlett Packard Enterprise
U.S. STOCKS ON THE MOVE-Nvidia, Trevena, Akili
Akili surges as video game shows improvement in adolescent ADHD patient trial
Brief: Akili Reports First Quarter 2023 Financial Results
Akili Inc expected to post a loss of 22 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ruth's Hospitality, Mirion Technologies, Qualcomm
U.S. STOCKS ON THE MOVE-CVS Health, Match Group, Western Union
Akili jumps as video game-based therapeutic helps ADHD patients
Brief: Akili Reports Fourth Quarter And Full Year 2022 Financial Results
Akili Inc expected to post a loss of 31 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Dream Finders Homes, Overstock.com, Vulcan Materials
Brief: Akili Inc Says Company's Workforce Will Be Reduced By About 30%
Brief: Akili Inc Announces Results From Pivotal Trial Of Endeavorrx In Adolescents With ADHD
U.S. RESEARCH ROUNDUP-Calithera Biosciences, Haynes International, Lumos Pharma